What Is Gonadorelin?

1. What is gonadorelin, and where does it fit in the hormone chain?

Andrew Schally’s group isolated GnRH from pig hypothalamus and published its 10-amino-acid structure in 1971 (Matsuo and colleagues’ sequence paper). Gonadorelin is that same peptide made synthetically. The veterinary Factrel label states that it matches the natural hormone in both sequence and physiological activity; PubChem lists a molecular weight of 1182.3 g/mol.

Products have used different salts, such as the hydrochloride (Factrel) and the acetate (Lutrepulse). The salt changes how much powder holds a given amount of peptide; the active hormone is the same.

The reproductive axis works as a relay, and gonadorelin enters at the second step. That position separates it from the other compounds people compare it with:

2. Why does pulse timing matter so much?

The hypothalamus releases GnRH in bursts. Several experiments showed that the pituitary reads the rhythm, not just the amount.

In the Matsumoto study, testosterone did not change significantly with either pattern over its short duration. Suppression is also not instant. When Fauser and colleagues gave 18 healthy men a 3-hour continuous infusion, LH rose 3–4 fold and testosterone up to 1.5 times baseline, much like pulses over the same period.

Long-acting analogs exploit the shutdown on purpose. According to the Lupron Depot label, leuprolide first raises LH, FSH and testosterone, then lowers testosterone to castrate levels, under 50 ng/dL, within two to four weeks. Gonadorelin itself disappears so quickly that a single injection behaves like one pulse unless it is infused continuously.

3. How long does gonadorelin last in the body?

Gonadorelin is cleared within minutes. The figures below come from small studies, but they point the same way.

The hormone it releases outlasts it slightly. In the Hurley study, LH peaked 20–30 minutes after the dose by either route, and 10 µg produced similar LH peaks IV and under the skin (15.2 vs 13.2 IU/L). Repeated subcutaneous pulses 90 minutes apart each produced a fresh LH response.

A half-life chart for gonadorelin therefore drops to near zero within a couple of hours. That curve describes the peptide in blood, not how long LH, testosterone or sperm production stay changed.

4. What do the fertility studies show?

Women with hypothalamic amenorrhea

Restoring ovulation in women whose hypothalamus had stopped producing GnRH was Lutrepulse’s approved purpose, and it has the deepest evidence.

In the Filicori series, 3 of the 4 multiple pregnancies were in women with some remaining hypothalamic activity who received the higher 5 µg dose. Polycystic ovary syndrome is a different picture: a Cochrane review found only 4 small randomized trials, 57 women in total, and could not show benefit or harm.

Men who cannot make GnRH

Hypogonadotropic hypogonadism means low testosterone because the brain does not send the GnRH signal. Here a pump can stand in for the missing hypothalamus.

The meta-analysis authors noted the absence of high-quality randomized trials. Pump therapy also asks a lot of patients: men in the Zhang study replaced the needle, reservoir and tubing every 3 days.

A one-time pituitary test

A single 100 µg IV bolus has been used in research to gauge how much LH the pituitary can release, for example in Finkelstein and colleagues’ studies of testosterone feedback. That is a diagnostic use: it shows what the pituitary can do at one moment and is not a treatment.

5. Can gonadorelin replace hCG during testosterone therapy?

This is the question most readers arrive with, and no published controlled trial answers it. Whether intermittent gonadorelin injections preserve testicular size, testosterone production inside the testes or fertility in men on testosterone has not been studied.

Two findings from the studies above argue for caution. First, every trial that restored testicular function delivered a pulse about every 1.5–2 hours by pump, and a subcutaneous dose is mostly gone within 90 minutes. Second, in 6 GnRH-deficient men already on pulsatile GnRH, a 4-day testosterone infusion lowered LH and FSH, showing that testosterone dampens the pituitary’s own response to GnRH (Finkelstein et al., 1991). An aromatase inhibitor blocked that effect, pointing to testosterone’s conversion to estradiol.

hCG sidesteps both issues because it acts on the testes directly. Men focused on sperm production specifically may also see FSH discussed, which works on a different cell type. Neither comparison establishes how gonadorelin would perform in this setting.

6. Is gonadorelin approved or legal?

Former human products

FDA does not host labels for either product. Lutrepulse was designed as a kit for pulsatile IV therapy in women with hypothalamic amenorrhea.

Veterinary products

Factrel is now a Zoetis cattle product used for ovarian follicular cysts and, with dinoprost, for timing ovulation before artificial insemination. Other cattle products such as Cystorelin are labeled “Not for use in humans.”

Compounding

With no marketed human product, US human use depends on compounding pharmacies. FDA’s compounding guidance is explicit that compounded drugs are not FDA-approved and are not checked for safety, effectiveness or quality before sale.

• 503A pharmacies may compound from bulk substances that are components of an FDA-approved drug, among other routes, according to FDA’s 503A page. Both gonadorelin salts were components of approved products.
• 503B outsourcing facilities: gonadorelin acetate sits in category 1, “under evaluation,” on FDA’s March 2025 nominations list.
• Safety-risk list: gonadorelin is not on FDA’s list of substances that raise significant safety risks. Kisspeptin-10 was added to that list in 2023.

Gonadorelin is not a controlled substance and does not appear in the DEA’s Schedule III anabolic steroid list.

Sport

The WADA 2026 Prohibited List bans GnRH, gonadorelin and its agonist analogs in males at all times, under section S2.2.1. The same section also covers hCG, LH and kisspeptin.

7. What are the side effects and risks?

• Allergic reactions. Skin and injection-site allergy was a common problem with the pump in the Zhang study, and the Wei meta-analysis found allergic reactions mainly with GnRH therapy. One woman on a Factrel pump developed wheal-and-flare reactions traced to antibodies against the hormone itself (Foster et al., 1989).
• Anaphylaxis. An 8-year-old girl collapsed within 3 minutes of an IV gonadorelin acetate test and needed epinephrine. The authors called such reactions extremely rare and recommended testing where they can be treated (Akın et al., 2015).
• IV-line problems. In the Lutrepulse trial, complications from the indwelling line averaged 7% (range 0–11%), and superficial vein inflammation is a recognized, uncommon issue with IV pumps.
• Multiple pregnancy. It occurred in 12% of women in the Lutrepulse trial. Ovarian hyperstimulation occurred once, in a woman also taking clomiphene.
• Suppression. Continuous exposure does not stimulate and, if sustained, can turn the axis off, the same principle long-acting analogs use.
• Product quality. Compounded and “research” vials have not had their identity, purity or sterility verified by FDA. Lutrepulse’s developers suggested that impurities and breakdown products in earlier GnRH preparations might have contributed to reactions (Wong et al., 1990).

In men, the Wei meta-analysis found more gynecomastia and acne with hCG/hMG than with pulsatile GnRH.

8. Interactions, including GLP-1 medicines

The sources reviewed here contain no study of gonadorelin used with semaglutide, tirzepatide or any other GLP-1 drug. That means there is no evidence of an interaction and no evidence of its absence.

The documented hormonal interactions are with sex steroids. Testosterone blunts the pituitary’s response to gonadorelin, apparently through estradiol, and continuous GnRH exposure or a long-acting analog such as leuprolide pushes the same pathway toward suppression. In one Lutrepulse case, hyperstimulation occurred alongside clomiphene.

9. What can you actually measure?

Gonadorelin itself is gone from blood within a couple of hours, so its effects are judged by what happens downstream. Each marker answers a different question.

Timing shapes interpretation. A single LH value drawn hours after a dose may simply miss the pulse, and sperm counts change over months, not weeks. Recording each dose time, product, every lab result with its draw time, and any skin reactions gives a clinician a usable timeline. The peptide tracking guide covers ways to keep those records together.

10. Gonadorelin FAQ

• Is gonadorelin the same as GnRH?

  Yes. Gonadorelin is the synthetic version of the natural 10-amino-acid hormone, with the same sequence and activity. Long-acting drugs such as leuprolide are modified analogs, not gonadorelin.

• Is gonadorelin FDA-approved?

  Two human products were approved, Factrel in 1982 and Lutrepulse in 1989, and both are now listed as discontinued. Gonadorelin remains approved for cattle. Human gonadorelin in the US today comes from compounding pharmacies, and FDA does not review compounded drugs before they are sold.

• Is gonadorelin legal?

  It is not a DEA-controlled substance and is not on FDA's list of bulk substances that raise significant compounding safety risks. It is a prescription drug when compounded. WADA prohibits it at all times in male athletes.

• Can gonadorelin replace hCG on TRT?

  This has not been tested in a published controlled trial. Studies that restored testicular function used pumps delivering a pulse every 1.5–2 hours, and testosterone itself blunts the pituitary's response to GnRH. hCG acts on the testes directly and does not depend on the pituitary.

• How long does gonadorelin stay in your system?

  Not long. After an IV injection, blood levels halve in about 2–3 minutes. After a subcutaneous injection in one study, levels peaked at 5–10 minutes and fell under 10% of peak by 90 minutes. The LH response it triggers peaked 20–30 minutes after the dose.

• What are the side effects of gonadorelin?

  Reported problems include skin and injection-site allergic reactions, rare anaphylaxis, IV-line complications with pump therapy, and multiple pregnancy when used for ovulation induction. Continuous exposure can suppress the reproductive axis instead of stimulating it.

• Can gonadorelin be used with semaglutide or tirzepatide?

  No study in the sources reviewed here tested gonadorelin together with a GLP-1 medicine, so there are no data on an interaction in either direction. Anyone combining treatments should tell the prescriber about every product being used.

• Does gonadorelin raise testosterone?

  It can, but only through the pituitary and testes, and only with the right timing. In GnRH-deficient men, pump therapy raised testosterone from 77 to 520 ng/dL over a month. In a short study, neither pulsed nor continuous gonadorelin raised testosterone significantly.

11. Sources